EARLY EFFECT OF 25-HYDROXYCHOLECALCIFEROL (25-OH-D3) AND 1,25-DIHYDROXYCHOLECALCIFEROL (1,25-(OH)2-D3) ON ABILITY OF PARATHYROID-HORMONE (PTH) TO ELEVATE CYCLIC-AMP OF INTACT BONE-CELLS

被引：28
|
作者：
MAHGOUB, A [1 ]
SHEPPARD, H [1 ]
机构：
[1] HOFFMANN LA ROCHE INC,RES DIV,DEPT CELL BIOL,NUTLEY,NJ 07110
来源：
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1975年 / 62卷 / 04期
关键词：
D O I：
10.1016/0006-291X(75)90408-8
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：901 / 907
页数：7
相关论文
共 50 条
  • [1] FAILURE OF 1,25 DIHYDROXYCHOLECALCIFEROL [1,25-(OH)2-D3] TO MODIFY CYCLIC-AMP LEVELS IN PARATHYROID HORMONE-TREATED AND UNTREATED BONE-CELLS
    PECK, WA
    DOWLING, I
    ENDOCRINE RESEARCH COMMUNICATIONS, 1976, 3 (02): : 157 - 166
  • [2] LACK OF A DIRECT EFFECT OF 1,25-DIHYDROXYCHOLECALCIFEROL (1,25(OH)2D3) ON SECRETION OF PARATHYROID-HORMONE
    GOLDEN, P
    GREENWALT, A
    MARTIN, K
    BELLORINFONT, E
    MAZEY, R
    KLAHR, S
    SLATOPOLSKY, E
    KIDNEY INTERNATIONAL, 1979, 16 (06) : 816 - 816
  • [3] LACK OF A DIRECT EFFECT OF 1,25-DIHYDROXYCHOLECALCIFEROL (1,25(OH)2D3) ON SECRETION OF PARATHYROID-HORMONE
    GOLDEN, P
    GREENWALT, A
    MARTIN, K
    BELLORINFONT, E
    MAZEY, R
    KLAHR, S
    SLATOPOLSKY, E
    CLINICAL RESEARCH, 1979, 27 (04): : A665 - A665
  • [4] THERAPEUTIC EXPERIENCES WITH 25-OH-D3, 1ALPHA-OH-D3 AND 1,25-(OH)2-D3
    KIND, HP
    WERDER, E
    FANCONI, A
    PRADER, A
    HELVETICA PAEDIATRICA ACTA, 1975, : 17 - 17
  • [5] BYPASS OF PARATHYROID-HORMONE-STIMULATED CAMP PATHWAY IN CULTURED BONE-CELLS BY 1,25-DIHYDROXYCHOLECALCIFEROL [1,25(OH)2D3]
    WONG, GL
    LUBEN, RA
    COHN, DV
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 910 - 910
  • [6] 25-OH-D3及1,25-（OH）2-D3的研究进展
    杨德智
    广东饲料, 2012, 21 (02) : 24 - 27
  • [7] 1, 25-Dihydroxycholecalciferol (1,25-(OH)2 D3) levels in osteoporosis
    Narang A.P.S.
    Batra S.
    Sabharwal S.
    Ahuja S.C.
    Indian Journal of Clinical Biochemistry, 2004, 19 (2) : 111 - 113
  • [8] RHABDOMYOLYSIS INDUCED ACUTE-RENAL-FAILURE (ARF) - INTERACTIONS OF CALCIUM (CA), PARATHYROID-HORMONE (PTH), 25-HYDROXYCHOLECALCIFEROL (25D3) AND 1,25-DIHYDROXYCHOLECALCIFEROL (1,25D3)
    LLACH, F
    FELSENFELD, AJ
    HAUSSLER, MR
    KIDNEY INTERNATIONAL, 1981, 19 (01) : 114 - 114
  • [9] ROLE OF 1,25 DIHYDROXYCHOLECALCIFEROL (1,25(OH)2D3) IN SKELETAL RESISTANCE TO CALCEMIC ACTION OF PARATHYROID-HORMONE (PTH) IN UREMIA
    MASSRY, SG
    STEIN, R
    GARTY, J
    ARIEFF, AI
    COBURN, JW
    NORMAN, AW
    CLINICAL RESEARCH, 1975, 23 (02): : A140 - A140
  • [10] EFFECTS OF 1,25-DIHYDROXYCHOLECALCIFEROL (1,25 (OH)2-D3) ON INVITRO COLON-TUMOR GROWTH
    LOINTIER, P
    WARGOWITCH, MJ
    KAUFFMANN, P
    MAURAS, JR
    CHIPPONI, J
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1987, 11 (2BIS): : A7 - A7
12345